Home Business Hone Health lands $228 million with backing from Jay-Z’s firm and Gwyneth...

Hone Health lands $228 million with backing from Jay-Z’s firm and Gwyneth Paltrow. She’s an investor—and a patient

0
2

When Saad Alam was 35, he told his doctor he was depressed and gaining weight even though he ate well, slept well, and had been an athlete his whole life. The doctor quickly gave him an answer.

“He literally said, ‘Well, South Asian men start to age a little bit early, so let me give you Viagra and an antidepressant,’” Alam told Fortune. “And I was like, ‘That’s complete bullsh-t.’”

So, Alam decided to look for a second opinion. After months of visits to endocrinologists, urologists, and cardiologists, a group of doctors told him he had low testosterone. That led him in 2020 to cofound Hone Health, an online clinic that began by treating men with low testosterone.

Six years later, Hone announced $228 million in new financing, including a $28 million equity round led by MarcyPen Capital Partners, the investment firm cofounded by Shawn “Jay-Z” Carter, Jay Brown, and Robbie and D’Rita Robinson.

Hone Health’s announcement on Wednesday also discloses that MarcyPen led Hone’s Series A, a role the company had not made public.

Asked why, Hone said in a statement that MarcyPen “has historically maintained a low public profile, allowing their portfolio companies to remain at the center of their own stories.” Alam told Fortune it’s even simpler for MarcyPen: “Here’s the capital. You guys let the company do all the work, and we want the company to shine—not necessarily everyone that’s surrounding it. They’re quiet on every single one.”

MarcyPen formed in 2024 when Jay-Z’s Marcy Venture Partners merged with Pendulum Holdings’ investment arm.

“Saad and the team at Hone are proven business builders dedicated to making it easier for people to live better, healthier lives,” Jay Brown said in the announcment. Charlie Hanna, a managing director at MarcyPen, said the firm has “been incredibly impressed by their ambition and execution.”

Courtesy of Hone

The celebrity cap table

Other backers in the equity round include Kinship Ventures, the firm Gwyneth Paltrow cofounded with Moj Mahdara, along with Pentland Ventures, Hanwha, Gannet Capital, and Humbition. Individual investors include the Jonas Brothers (Nick, Joe, and Kevin Jonas), singer Kelly Rowland, actor Marcello Hernández, hospitality entrepreneurs David Grutman, Jason Strauss and Noah Tepperberg, and Quentin Dolan, whose father controls the New York Knicks.

Paltrow said she is also a patient.

“I did all my labs and blood work and everything. I started a protocol that was incredibly helpful,” she said. “We found gut bacteria; my hormones were unbalanced. It’s amazing how everything turned right side up.”

“The next great health company will be built on data,” Mahdara said in Hone’s announcement.

Tepperberg said Grutman introduced him to Hone, and that he has started referring family and friends. Asked whether he sees himself as an investor or a promoter, he said: “all of the above.”

His Tao Group Hospitality co-CEO, Strauss, said he has been into longevity medicine “for decades.”

“I live a very demanding lifestyle and I want to not only feel my best today, but live as many years as possible in good health,” he said.

Rowland said she wants more people, “especially women,” to take control of their health.

“I want to be stronger in my 50s than I was in my 30s,” she said.

Alam said he pitched Dolan when Hone launched six years ago and was told it was too early. Dolan came up through the Knicks’ athletic side, working with trainers on the kind of measurement Hone does with patients, Alam said.

Courtesy of Hone

How the $228 million breaks down

Only $28 million of the money is equity, raised as an extension of Hone’s Series A rather than a Series B. The other $200 million comes from General Catalyst’s Customer Value Fund, which pays for a large share of a company’s sales and marketing and is repaid from the revenue the new customers bring in.

Alam said he can call General Catalyst each month and ask for $10 million, spend it acquiring patients, then pay back a portion of the profit from those patients plus interest. Unlike a bank loan, he said, the deal has no recourse and no covenants restricting Hone from raising other money.

“It’s actually shocking how small the interest rate is on it,” he said.

General Catalyst only offers the deal to companies whose patients stay at a steady rate, he said. Hone broke through $100 million in recurring revenue last year, according to Alam, and has treated about 200,000 patients since it launched. In January 2025 it reported 55,000 patients treated. The new round brings Hone’s total equity funding to $65 million.

Alam said most of the $28 million will go to AI that lets one physician handle problems that would normally send a patient to several specialists.

“People have never had more data about their own bodies and never less guidance on what to do with it,” said Omar Hatteea, an investment manager at Pentland Ventures.

A concierge tier for the famous

Hone is also launching Hone Black, a concierge membership that has run in stealth for a small group of high-profile patients. It pairs testing of more than 1,600 health markers with a dedicated team of physicians. The program, Alam said, began when people asked how he kept up his energy at 44. He calls it a test bed for treatments that may later reach Hone’s main product.

“Our risk profile is a little bit different,” he said of Hone Black patients. “We’re willing to try things that are a little bit more on the edge, but have to do it safely.”

Alam said Hone is the first business under a parent company, Time Therapeutics. His plan has three stages: build a large online clinic, use its patient base to run clinical trials remotely, then partner with drugmakers and research centers to bring drugs to market faster in exchange for equity.

“If you fail, this is your final step,” he said of the clinic. “You’re still going to be able to impact a bunch of lives.”

Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: fortune.com